Publications by authors named "Maria Badiola"

Claim this Profile
A
A Phase I/II Clinical Trial of Intradermal, Controllable Self-Replicating Ribonucleic Acid Vaccine EXG-5003 against SARS-CoV-2.
Takenao Koseki, Mayumi Teramachi, Minako Koga, Minoru S H Ko, Tomokazu Amano, Maria Badiola

Vaccines (Basel)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunity.
Tomokazu Amano, Hong Yu, Misa Amano, Erica Leyder, Maria Badiola

iScience· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunity.
Tomokazu Amano, Hong Yu, Misa Amano, Erica Leyder, Maria Badiola

bioRxiv· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis